EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-Marker Evaluation of Creatinine, Cystatin C and β2-Microglobulin for GFR Estimation in Stage 3–4 CKD Using the 2021 CKD-EPI Equations

Nurulamin Abu Bakar, Nurul Izzati Hamzan iD, Siti Nurwani Ahmad Ridzuan iD, Izatus Shima Taib iD, Zariyantey Abdul Hamid, Anasufiza Habib iD, Noor Hafizah Hassan iD

International Journal of Molecular Sciences · 15.01.2026 · 27 (2) · 862

DOI: 10.3390/ijms27020862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.01.2026. Verfasst von Nurulamin Abu Bakar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Diagnostics, Therapeutics and Investigative Studies (CODTIS), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda A…. Hauptthemen laut MEDLINE: Cystatin C, beta 2-Microglobulin, Glomerular Filtration Rate, Creatinine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute for Medical Research, Universiti Kebangsaan Malaysia, National Medical Research Register.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is a progressive disease in which accurate estimation of glomerular filtration rate (GFR) is essential for staging and guiding therapy. Serum creatinine is widely used but influenced by non-renal factors, while cystatin C and β2-microglobulin (β2M) may provide complementary information related to filtration and tubular or inflammatory factors. This study compared the discriminatory performance of creatinine, cystatin C and β2M for separating CKD stage 3 from stage 4 within the 2021 CKD-EPI eGFR framework in 45 adults with CKD stages 3–4. CKD stage classification was defined using the 2021 CKD-EPI creatinine and creatinine–cystatin C equations (eGFRcr, eGFRcr–cys) with a threshold of 30 mL/min/1.73 m2. Receiver operating characteristic (ROC) analysis evaluated each marker’s ability to distinguish moderate from severe CKD. Creatinine showed high diagnostic accuracy (AUC up to 0.98). Cystatin C achieved 100% specificity at the optimal cut-off for severe CKD and showed comparable diagnostic accuracy to creatinine under the eGFRcr–cys framework (AUC 0.978 vs. 0.957). β2M demonstrated AUCs up to 0.97, with sensitivity and specificity above 90%. These findings support a multi-marker evaluation within the 2021 CKD-EPI-based staging, rather than validation against measured GFR. Larger studies incorporating measured GFR and relevant clinical confounders are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystatin Cbeta 2-MicroglobulinGlomerular Filtration RateCreatinineBiomarkersRenal Insufficiency, ChronicHumansFemaleMaleMiddle AgedROC CurveAgedAdult

Stichwörter der Autor:innen

2021 CKD-EPI equationsROC curvechronic kidney disease (CKD)cystatin Cdiagnostic accuracyglomerular filtration rate (GFR)molecular biomarkersserum creatininestage 3–4 CKDβ2-microglobulin (β2M)

Substanzen

Cystatin Cbeta 2-MicroglobulinCreatinineBiomarkers

Autor:innen und Institutionen

  • Centre of Diagnostics, Therapeutics and Investigative Studies (CODTIS), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
  • Special Protein Unit, Specialized Diagnostic Centre, Institute for Medical Research, National Institutes of Health, Jalan Pahang, Kuala Lumpur 50588, Malaysia.
  • Specialized Diagnostic Centre, Institute for Medical Research, National Institutes of Health, Jalan Pahang, Kuala Lumpur 50588, Malaysia.

ORCID-Profile: Nurul Izzati Hamzan, Siti Nurwani Ahmad Ridzuan, Izatus Shima Taib, Anasufiza Habib, Noor Hafizah Hassan

Förderung

  • Institute for Medical Research
  • Universiti Kebangsaan Malaysia
  • National Medical Research Register
  • Institute for Medical Research (IMR), National Institutes of Health (NIH), Ministry of Health Malaysia.

Zitieren

APA

Abu Bakar, N., Hamzan, N. I., Ahmad Ridzuan, S. N., Taib, I. S., Abdul Hamid, Z., Habib, A., & Hassan, N. H. (2026). Multi-Marker Evaluation of Creatinine, Cystatin C and β2-Microglobulin for GFR Estimation in Stage 3–4 CKD Using the 2021 CKD-EPI Equations. International Journal of Molecular Sciences, 27(2), 862. https://doi.org/10.3390/ijms27020862

Vancouver

Abu Bakar N, Hamzan NI, Ahmad Ridzuan SN, Taib IS, Abdul Hamid Z, Habib A, et al. Multi-Marker Evaluation of Creatinine, Cystatin C and β2-Microglobulin for GFR Estimation in Stage 3–4 CKD Using the 2021 CKD-EPI Equations. International Journal of Molecular Sciences. 2026;27(2):862. doi:10.3390/ijms27020862

BibTeX
@article{AbuBakar2026,
  author = {Abu Bakar, Nurulamin and Hamzan, Nurul Izzati and Ahmad Ridzuan, Siti Nurwani and Taib, Izatus Shima and Abdul Hamid, Zariyantey and Habib, Anasufiza and Hassan, Noor Hafizah},
  title = {Multi-Marker Evaluation of Creatinine, Cystatin C and β2-Microglobulin for GFR Estimation in Stage 3–4 CKD Using the 2021 CKD-EPI Equations},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {2},
  pages = {862},
  doi = {10.3390/ijms27020862}
}
Kostenlos starten →